Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211
- 10 November 2012
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (32), 4044-4046
- https://doi.org/10.1200/jco.2012.45.6541
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Peripheral T-cell lymphomaBlood, 2011
- Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma StudyJournal of Clinical Oncology, 2009
- Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211Journal of Clinical Oncology, 2009
- Angiocentric Lymphoma of the Head and Neck: Patterns of Systemic Failure After Radiation TreatmentJournal of Clinical Oncology, 2000